SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

Doctors are currently using stem cells to treat a variety of medical conditions — and that list could soon become even larger ...

Those market dynamics will again be in focus when Novo reports results for its diabetes drug Ozempic and weight-loss ... get ...

Our list of online ... brand-name semaglutide medications. The primary difference is the dosing and FDA approval. Wegovy is ...

Ozempic is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help with blood sugar control ...